Performance and post-treatment conversion of latent tuberculosis test (QUANTIFERON) in immunocompromised patients with neoplasmatic disease

G. Hardavella, A. Charpidou, N. Rovina, M. Salomidou, S. Karabela, I. Gkiozos, N. Poulakis (Athens, Greece)

Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis
Session: Immune responses for the diagnosis of tuberculosis
Session type: E-Communication Session
Number: 280
Disease area: Respiratory infections, Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Hardavella, A. Charpidou, N. Rovina, M. Salomidou, S. Karabela, I. Gkiozos, N. Poulakis (Athens, Greece). Performance and post-treatment conversion of latent tuberculosis test (QUANTIFERON) in immunocompromised patients with neoplasmatic disease. Eur Respir J 2010; 36: Suppl. 54, 280

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
New skin test with recombinant protein CFP10-ESAT6 in patients (children and adults) with tuberculosis, non-tuberculosis disease and latent TB infection
Source: Annual Congress 2012 - Tuberculosis and immunologic assays
Year: 2012


Skin test reactivity in non HIV pediatric patients exposed to TB active lung disease. Predictor of active disease
Source: Eur Respir J 2005; 26: Suppl. 49, 413s
Year: 2005

Performance of blood tests for the diagnosis of latent tuberculosis infection in children
Source: Annual Congress 2008 - New methods to diagnose tuberculosis infection and disease
Year: 2008

The role of quantiferon tuberculosis gold test (Q) in diagnosing active tuberculosis (TB) and latent tuberculosis infection (LTI) in children
Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment
Year: 2008


Impact of T-SPOT.TB test to exclude active Mycobacterium tuberculosis complex infection in patients with mycobacterial disease
Source: Eur Respir J 2006; 28: Suppl. 50, 139s
Year: 2006

Risk of developing tuberculosis disease among persons diagnosed with latent tuberculosis infection in the Netherlands
Source: Eur Respir J 2016; 48: 1420-1428
Year: 2016



Comparison of Quanti-FERON-TB Gold and tuberculin skin test for diagnosis of latent tuberculosis infection in patients with chronic schizophrenia
Source: Annual Congress 2010 - What is new in the diagnosis of tuberculosis?
Year: 2010


Pulmonary disease caused by M. malmoense in HIV negative patients: 5-yr follow-up of patients receiving standardised treatment
Source: Eur Respir J 2003; 21: 478-482
Year: 2003



Evaluating the use of the interferon-γ response to mycobacterium tuberculosis (MTB) specific antigens to diagnose latent tuberculosis infection in patients with chronic inflammatory joint and skin diseases
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011

Comparison of the tuberculin skin test and the ELISPOT blood test for the diagnosis of latent tuberculosis infection in pre-transplant dialysis patients
Source: Annual Congress 2005 - Diagnosis of tuberculosis and LTBI
Year: 2005


Benefit of treatment of latent tuberculosis infection in individual patients
Source: Eur Respir J 2016; 47:1592-1594
Year: 2016


Benefit of treatment of latent tuberculosis infection in individual patients
Source: Eur Respir J 2016; 47:1594-1595
Year: 2016


Benefit of treatment of latent tuberculosis infection in individual patients
Source: Eur Respir J 2015; 46: 1397-1406
Year: 2015



Interferon-γ release assays (IGRA) vs. tuberculin skin testing (TST) for detecting latent tuberculosis infection (LTBI) in chronic hemodialysis (CH) patients
Source: Annual Congress 2008 - New tools in tuberculosis diagnosis
Year: 2008



What is latent tuberculosis infection (LTBI)?
Source: Annual Congress 2009 - Microbial colonisation or latency: a foot in the door to respiratory infections
Year: 2009


Quantiferon test in the complex diagnosis of tuberculosis in patients with end-stage kidney disease
Source: Virtual Congress 2020 – Tuberculosis and society
Year: 2020


Diagnosis of latent tuberculosis infection in patients with chronic liver disease undergoing liver transplantation: performance of the new IFN-γ-based assays
Source: Eur Respir J 2007; 30: Suppl. 51, 752s
Year: 2007

Comparison of the tuberculin skin test and the RD1 elispot for the diagnosis of latent tuberculosis infection in renal transplant patients
Source: Eur Respir J 2006; 28: Suppl. 50, 142s
Year: 2006

Evaluation of D-dimer levels in patients with active pulmonary tuberculosis and latent tuberculosis infection
Source: Eur Respir J 2006; 28: Suppl. 50, 164s
Year: 2006

Comparison of effector T-cell responses in patients with active TB disease compared to latent TB infection
Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease
Year: 2007